Evidence map›Paper›PMID 39023360›Full record

ArticleACS infectious diseases2024

Evaluation of the

Edubiel A Alpizar-Sosa, Flavia M Zimbres, Brian S Mantilla, Emily A Dickie, Wenbin Wei, Gabriela A Burle-Caldas, Laura N S Filipe, Katrien Van Bocxlaer, Helen P Price, Ana V Ibarra-Meneses and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Edubiel A Alpizar-SosaDepartment of Biosciences, University of Durham, South Road, Durham, DH1 3LE, U.K.
Flavia M ZimbresDepartment of Biosciences, University of Durham, South Road, Durham, DH1 3LE, U.K.
Brian S MantillaDepartment of Biosciences, University of Durham, South Road, Durham, DH1 3LE, U.K.
Emily A DickieSchool of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, U.K.ORCID 0000-0002-4509-5045
Wenbin WeiDepartment of Biosciences, University of Durham, South Road, Durham, DH1 3LE, U.K.
Gabriela A Burle-CaldasDepartment of Biosciences, University of Durham, South Road, Durham, DH1 3LE, U.K.
Laura N S FilipeDepartment of Biosciences, University of Durham, South Road, Durham, DH1 3LE, U.K.
Katrien Van BocxlaerYork Biomedical Research Institute, Hull York Medical School, University of York, York YO10 5NG, U.K.
Helen P PriceSchool of Life Sciences, Keele University, Staffordshire, ST5 5BG, U.K.ORCID 0000-0003-1537-4390
Ana V Ibarra-MenesesDépartement de Pathologie et Microbiologie, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec J2S 2M2, Canada.
Francis BeaudryDépartement de Biomédecine, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec J2S 2M2, Canada.
Christopher Fernandez-PradaDépartement de Pathologie et Microbiologie, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec J2S 2M2, Canada.ORCID 0000-0003-4834-4956
Philip D WhitfieldSchool of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, U.K.
Michael P BarrettSchool of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, U.K.
Paul W DennyDepartment of Biosciences, University of Durham, South Road, Durham, DH1 3LE, U.K.ORCID 0000-0002-5051-1613

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lack of effective vaccines and the development of resistance to the current treatments highlight the urgent need for new anti-leishmanials. Sphingolipid metabolism has been proposed as a promising source of

Indexed as

Antiprotozoal AgentsAnimalsGlycosphingolipidsHexosyltransferasesLeishmaniaLeishmania mexicanaSphingolipidsTransferases (Other Substituted Phosphate Groups)Antiprotozoal AgentsGlycosphingolipidsHexosyltransferasesinositolphosphorylceramidephosphatidylinositol-ceramide phosphoinositol transferaseSphingolipidsTransferases (Other Substituted Phosphate Groups)clemastine fumarateCRISPR-Cas9inositol phosphorylceramide synthaseLeishmaniapolyomicsthermal proteomic profiling

Identifiers

PMID39023360
PMCPMC11320567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.